The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastu1
A study led by Clínic Barcelona-IDIBAPS, in collaboration with the Healthcare Quality and Evaluation Agency of Catalonia (AQuAS), has for the first t1
On 26 September 2025, the Kidney Transplant Service at the Hospital Clínic Barcelona performed the first treatment with autologous tolerogenic dendri1
Professionals from Hospital Clínic-IDIBAPS are leading two projects in medical technology innovation and two in advanced drug and therapy development1
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Annua1
This October, ICREA researcher Susana de la Luna joined the IDIBAPS research group “Gene therapy and cancer”, led by Cristina Fillat.
The research shows that these immune changes can appear up to a year before a cancer diagnosis, opening new possibilities for early detection.
IDIBAPS researchers develop a pioneering tool to model the progression of alcohol-associated liver disease and identify new treat1
The project led by Pere Santamaria will study nanodrugs to combat autoimmune diseases such as type 1 diabetes. The proj1
